OTTAWA, April 6 /CNW/ - Canada's Research-Based Pharmaceutical Companies
(Rx&D) President Russell Williams, is pleased to welcome a new member
to the association representing the innovative pharmaceutical industry
EndoCeutics Inc., which is based in Quebec City, has joined Rx&D as a
EndoCeutics is a private bio-pharma company operating in the field of
women's health and is focused on developing non-estrogen-based
therapies for problems of menopause, as well as hormone therapy for
prevention and treatment of Breast Cancer.
"We've succeeded in creating a world-class health research centre
specialized in the mechanisms of menopause and hormone-sensitive
cancers," said Dr. Fernand Labrie, President and CEO of EndoCeutics
Inc. "Joining Rx&D is another step in building our capacity and
capability so we can continue to develop products that save lives and
improve the quality of life of patients worldwide while benefiting the
economy of Quebec and Canada."
EndoCeutics was established in 2006 as the late-stage development and
commercialization vehicle for EndoResearch Inc., a company responsible
for major advances in the field of prostate cancer.
"More and more companies of Canada's life sciences sector are
recognizing the value and benefits of becoming members of Rx&D. We are
pleased to welcome EndoCeutics as a member our association," said Rx&D
President Russell Williams.
Rx&D is the association of leading research-based pharmaceutical
companies dedicated to improving the health of Canadians through the
discovery and development of new medicines and vaccines. Our community
represents 15,000 men and women working for 50 member companies and
invests more than $1 billion in research and development each year to
fuel Canada's knowledge-based economy. Guided by our Code of Ethical
Practices, our membership is committed to working in partnership with
governments, healthcare professionals and stakeholders in a highly
SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX
For further information:
Mike Murphy, Communications